Balentine LLC Sanofi Transaction History

Balentine LLC

$2.54 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$45.75 - $52.48 $109,754 - $125,899	2,399 Added 11.89%	22,569 $1.1 Million
Q4 2023 Feb 09, 2024	SELL	$43.13 - $54.79 $376,869 - $478,755	-8,738 Reduced 30.23%	20,170 $1 Million
Q3 2023 Nov 13, 2023	BUY	$50.95 - $55.2 $300,095 - $325,128	5,890 Added 25.59%	28,908 $1.55 Million
Q2 2023 Aug 14, 2023	BUY	$50.45 - $57.18 $21,996 - $24,930	436 Added 1.93%	23,018 $1.24 Million
Q1 2023 May 11, 2023	BUY	$45.86 - $54.45 $86,446 - $102,638	1,885 Added 9.11%	22,582 $1.23 Million
Q4 2022 Jan 31, 2023	BUY	$38.86 - $48.55 $176,385 - $220,368	4,539 Added 28.09%	20,697 $1 Million
Q3 2022 Oct 26, 2022	BUY	$37.22 - $100.5 $67,182 - $181,402	1,805 Added 12.58%	16,158 $614,000
Q2 2022 Oct 26, 2022	BUY	$48.99 - $57.46 $258,373 - $303,044	5,274 Added 58.09%	14,353 $718,000
Q2 2022 Aug 15, 2022	BUY	$48.99 - $57.46 $258,373 - $303,044	5,274 Added 58.09%	14,353 $718,000
Q1 2022 Oct 26, 2022	SELL	$48.48 - $53.65 $255,683 - $282,950	-5,274 Reduced 36.74%	9,079 $466,000
Q1 2022 May 06, 2022	BUY	$48.48 - $53.65 $163,813 - $181,283	3,379 Added 59.28%	9,079 $466,000
Q4 2021 Oct 26, 2022	SELL	$47.07 - $52.35 $407,296 - $452,984	-8,653 Reduced 60.29%	5,700 $286,000
Q4 2021 Feb 02, 2022	BUY	$47.07 - $52.35 $268,299 - $298,395	5,700 New	5,700 $286,000
Q3 2021 Nov 15, 2021	SELL	$47.89 - $53.12 $191,703 - $212,639	-4,003 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$49.36 - $54.25 $197,588 - $217,162	4,003 New	4,003 $211,000
Q3 2020 Nov 02, 2020	SELL	$49.47 - $53.77 $128,176 - $139,318	-2,591 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$42.91 - $52.5 $111,179 - $136,027	2,591 New	2,591 $132,000
Q4 2019 Sep 02, 2020	SELL	$44.25 - $50.86 $29,426 - $33,821	-665 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$40.34 - $46.64 $5,082 - $5,876	126 Added 23.38%	665 $31,000
Q2 2019 Aug 14, 2019	SELL	$40.43 - $44.3 $7,600 - $8,328	-188 Reduced 25.86%	539 $23,000
Q1 2019 May 16, 2019	SELL	$40.83 - $45.43 $16,250 - $18,081	-398 Reduced 35.38%	727 $32,000
Q4 2018 Feb 13, 2019	BUY	$41.48 - $45.59 $30,736 - $33,782	741 Added 192.97%	1,125 $49,000
Q3 2018 Nov 14, 2018	BUY	$40.0 - $44.84 $5,920 - $6,636	148 Added 62.71%	384 $17,000
Q2 2018 Aug 14, 2018	BUY	$37.63 - $41.22 $8,880 - $9,727	236 New	236 $9,000
Q1 2018 May 16, 2018	SELL	$38.98 - $45.76 $2,338 - $2,745	-60 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$42.86 - $50.61 $2,228 - $2,631	-52 Reduced 46.43%	60 $3,000
Q3 2017 Nov 15, 2017	BUY	$47.04 - $50.34 $5,268 - $5,638	112	112 $6,000

Others Institutions Holding SNY

# of Institutions

820

Shares Held

274M

Call Options Held

Put Options Held

1.9M

Dodge & Cox San Francisco, CA

76.3M
Shares

$3.66 Billion
2.67% of portfolio
Morgan Stanley New York, NY

17.8M
Shares

$853 Million
0.08% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.4M
Shares

$641 Million
0.32% of portfolio
Invesco Ltd. Atlanta, GA

11.7M
Shares

$559 Million
0.13% of portfolio
Bank Of America Corp Charlotte, NC

11.6M
Shares

$555 Million
0.06% of portfolio

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $120B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.

Account